Marshall Wace North America’s Intersect ENT, Inc XENT Stock Holding History

Marshall Wace North America’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,756	Closed	-$201K	–	1885
2020 Q4	$201K	Buy	+8,756	New	+$167K	﹤0.01%	1229
2019 Q2	–	Sell	-557	Closed	-$18K	–	1773
2019 Q1	$18K	Sell	557 -9,721	-95%	-$301K	﹤0.01%	1399
2018 Q4	$290K	Buy	+10,278	New	+$301K	﹤0.01%	894
2018 Q3	–	Sell	-12,760	Closed	-$478K	–	1516
2018 Q2	$478K	Buy	+12,760	New	+$501K	﹤0.01%	1092
2018 Q1	–	Sell	-8,885	Closed	-$287K	–	1789
2017 Q4	$287K	Buy	+8,885	New	+$266K	﹤0.01%	1232
2017 Q2	–	Sell	-34,715	Closed	-$590K	–	1505
2017 Q1	$590K	Buy	+34,715	New	+$486K	﹤0.01%	794

Other funds holding XENT

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Marshall Wace North America's XENT Position: Q1 2021 in Review

Marshall Wace North America sold out of Intersect ENT, Inc (XENT) in Q1 2021, closing a stake of 8,756 shares — an estimated $201K sold.

Marshall Wace North America first reported a position in XENT in Q1 2017 and held it in 6 quarters. The position peaked at $590K in Q1 2017. 108 funds tracked by Wall St. Rank hold XENT as of Q1 2021.

Marshall Wace North America reported no remaining Intersect ENT, Inc position as of Q1 2021 after selling out during the quarter.
Marshall Wace North America sold 8,756 Intersect ENT, Inc shares in Q1 2021, an estimated $201K.
Marshall Wace North America first reported a position in Intersect ENT, Inc in Q1 2017 and held it in 6 quarters.
Marshall Wace North America's Intersect ENT, Inc position peaked at $590K in Q1 2017.
108 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.